BridgeBio have substantially advanced this progress of the new therapy for ATTR-CM, utilizing the investigational drug. Preliminary clinical results suggests potential outcomes for those affected by a severe disease. https://biotech341796.blogdanica.com/42313760/bridgebio-advances-attr-cm-therapy-with-the-therapy